FahimAbbasiMD

Internal Medicine • Stanford, CA

Physician

Join to view full profile

Dr. Abbasi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Abbasi's full profile

Already have an account?

Office
300 Pasteur Dr
Stanford, CA 94305
Phone+1 650-723-4000

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1995 - 1997
University of ConnecticutResidency, Internal Medicine, 1992 - 1995
King Edward Medical UniversityClass of 1988

Certifications & Licensure

CA State Medical License 1996 - 2026
CT State Medical License 1995 - 2000
American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Prediction of metabolic subphenotypes of type 2 diabetes via continuous glucose monitoring and machine learning.
Ahmed A Metwally, Dalia Perelman, Heyjun Park, Yue Wu, Alokkumar Jha
Nature Biomedical Engineering. 2024-12-23
Cross-sectional, interventional, and causal investigation of insulin sensitivity using plasma proteomics in diverse populations.
Pik Fang Kho, Neil Wary, Daniela Zanetti, Fahim Abbasi, Joshua W Knowles
Medrxiv. 2024-11-12
Plasma proteomic signatures for type 2 diabetes mellitus and related traits in the UK Biobank cohort.
Trisha P Gupte, Zahra Azizi, Pik Fang Kho, Jiayan Zhou, Kevin Nzenkue
Medrxiv. 2024-09-15

Lectures

Effect of Salsalate on Insulin Action, Secretion, and Clearance in Non-Diabetic, Insulin-Resistant Individuals: A Randomized, Placebo-Controlled Study
Stanford, CA - 6/14/2014
Sex Differences Modulate Relationships among Obesity, Insulin Resistance, and Obstructive Sleep Apnea
Stanford, CA - 6/15/2014

Press Mentions

Notification of Incidental Coronary Artery Calcium in Patients with Atherosclerotic Cardiovascular Disease (NOTIFY-ASCVD) (NOTIFY-ASCVD)May 15th, 2023
AI Identifies Risk of Cholesterol-Raising Genetic DiseaseApril 11th, 2019